John C. Davis Jr., Chief Medical Officer at Magenta Therapeutics, Inc. (MGTA), sold 919 shares at $15.00 ($14K) on 2019-12-20, disclosed to the SEC on 2019-12-20.
Scheduled sale ($14k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |